Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Hopes To Finalize Most 510(k) Reform Guidances In 2012

07 Nov 2011

Related Content

FDA Guidance Emphasizes Randomized, Blinded Trials For PMAs

22 Aug 2011

FDA Issues 510(k) Modifications Draft Guidance

01 Aug 2011

CDRH's Innovation Pathway: A Quicker Route For Breakthrough Devices?

14 Feb 2011

FDA Kicks Off 510(k) Reform Plan, Punts Some Decisions To IOM

24 Jan 2011

Additional Topics

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.